Platform presentations of selected Infectious Diseases abstracts.
ID07 - Evaluation of an automated rRNA quantitation system for rapid AST in clinical lab diagnostics
Dakai Liu, PhD, NewYork-Presbyterian Queens Hospital, Flushing, NY, USA
ID27 - Evaluating the Clinical Utility of Next-Generation Sequencing of Nasopharyngeal Specimens for
SARS-CoV-2 in the COVID-19 Pandemic
Priya Velu, MD, PhD, New York Presbyterian-Weill Cornell Medicine, New York, NY, USA
ID52 - Design and Optimization of Novel ITS2-28s rRNA Gene Primers for Fungal Species Detection from
Formalin-Fixed Paraffin-Embedded Tissues with a Targeted Next-Generation Sequencing Assay
Rossio K. Kersey, PhD, Joint Pathology Center, Bethesda, MD, USA
ID53 - Non-invasive Microbial Cell-free DNA Sequencing Detects Invasive Mold Infections in
Immunocompromised Patients with Pneumonia
Tim Blauwkamp, PhD, Karius, Inc., Redwood City, CA, USA
Objectives:
- Analyze platform presentations of abstracts highlighted by the Infectious Diseases Subdivision leadership as particularly significant.
- Evaluate the scientific merit and significance of these selected studies through further discussion with the authors.
Recording Date: November 17, 2020
Continuing Education Credit Information
This session is not eligible for CME/CMLE credit.
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
